In AML patients, mutation of the FLT3 gene is the most frequent genetic alteration featuring an internal tandem duplication (ITD) within the juxtamembrane domain and single-base mutations within the tyrosine kinase domain (TKD) 2, 4. The gene discussed is FLT3; the disease is acute myeloid leukemia.